Cargando…
Myasthenia Gravis Related to Small Cell Lung Carcinoma
Myasthenia gravis is a neuromuscular disease that causes weakness in skeletal muscles because of the presence of acetylcholine receptor antibodies. These antibodies produce a compromise in the end-plate potential, reducing the safety factor for effective synaptic transmission. Clinically, this manif...
Autores principales: | López-Viñas, Laura, Rocío-Martín, Esmeralda, Delis-Gómez, Salvador, Wix-Ramos, Rybel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046688/ https://www.ncbi.nlm.nih.gov/pubmed/33880245 http://dx.doi.org/10.7759/cureus.13889 |
Ejemplares similares
-
Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021) -
Myasthenia Gravis Associated With COVID-19 Infection
por: Sadiq, Waleed, et al.
Publicado: (2023) -
An Atypical Presentation of Myasthenia Gravis: A Case Report
por: Asghar, Hannan, et al.
Publicado: (2019) -
Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea
por: Khademolhosseini, Sara, et al.
Publicado: (2021) -
Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
por: Bastakoti, Sanjiv, et al.
Publicado: (2021)